{"title":"Can Ivermectin be Useful for COVID-19 Management as an Immunomodulating Agent?","authors":"S. Sheleg","doi":"10.2174/1874279302012010007","DOIUrl":null,"url":null,"abstract":"The possibility of using ivermectin in the treatment of COVID-19 as an immunomodulating agent, has been discussed, which may prevent lifethreatening virally driven cytokine storm syndrome.","PeriodicalId":88330,"journal":{"name":"The open infectious diseases journal","volume":"12 1","pages":"7-8"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open infectious diseases journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874279302012010007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The possibility of using ivermectin in the treatment of COVID-19 as an immunomodulating agent, has been discussed, which may prevent lifethreatening virally driven cytokine storm syndrome.